Industry sceptical as EU allays fears on FTA's impact on drug access
This article was originally published in Scrip
Executive Summary
India's role as a global supplier of low-cost generic medicines may not be hit as a result of the proposed Free Trade Agreement (FTA) with the European Union, according to details emerging from briefings following the ninth round of talks between India and the EU in Brussels last week.